Literature DB >> 30263391

Optimization of roasting conditions through antioxidant and anti-inflammatory activities of Yak-kong (Rhynchosia nulubilis).

Ae-Jung Kim1.   

Abstract

The effects of roasting conditions on the antioxidant activities and anti-inflammatory activities of roasted yak-kong were investigated using a second-order central composite design. The optimum conditions for DPPH radical scavenging ability (IC50), ABTS radical scavenging activity (IC50), total phenolic content (TPC), and oxygen radical absorbance capacity (ORAC) were at 111.47°C for 20.45 min, with the best values (DPPH, IC50; 2.143 mg/mL, ABTS, IC50; 1.775 mg/mL, TPC; 51.39mg tannic acid (TAE)/g, and ORAC; 6.89 μmoL trolox equivalents (TE)/g). The optimum conditions of nitric oxide (NO) production, prostaglandin E2 (PGE2) production, and tumor necrosis factor-α (TNF-α) were at 110.24°C for 21.18 min, yielding the best values (NO; 14.484 μM, PGE2; 3.433 mg/mL, and TNF-α; 3.818 ng/mL). Superimposed contour plots with regard to 7 variables indicated that the optimum roasting temperature and time were 110.88°C and 20.86 min. This result suggested that the optimally roasted yak-kong could replace coffee beans to provide potential bone health benefits to heavy coffee drinkers.

Entities:  

Keywords:  Yak-kong (seomoktae); antiinflammatory activity; antioxidant activity; response surface methodology; roasting

Year:  2016        PMID: 30263391      PMCID: PMC6049119          DOI: 10.1007/s10068-016-0187-3

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  28 in total

Review 1.  Antioxidant defence mechanisms: from the beginning to the end (of the beginning).

Authors:  B Halliwell
Journal:  Free Radic Res       Date:  1999-10

Review 2.  Who has osteoporosis? A conflict between clinical and public health perspectives.

Authors:  L J Melton
Journal:  J Bone Miner Res       Date:  2000-12       Impact factor: 6.741

3.  Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women.

Authors:  Xianglan Zhang; Xiao-Ou Shu; Honglan Li; Gong Yang; Qi Li; Yu-Tang Gao; Wei Zheng
Journal:  Arch Intern Med       Date:  2005-09-12

4.  Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women.

Authors:  H Hallström; A Wolk; A Glynn; K Michaëlsson
Journal:  Osteoporos Int       Date:  2006-05-04       Impact factor: 4.507

5.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

6.  Genistein and gut inflammation: role of nitric oxide.

Authors:  H Sadowska-Krowicka; E E Mannick; P D Oliver; M Sandoval; X J Zhang; S Eloby-Childess; D A Clark; M J Miller
Journal:  Proc Soc Exp Biol Med       Date:  1998-03

7.  Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants.

Authors:  N Salah; N J Miller; G Paganga; L Tijburg; G P Bolwell; C Rice-Evans
Journal:  Arch Biochem Biophys       Date:  1995-10-01       Impact factor: 4.013

Review 8.  Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism.

Authors:  Stavros C Manolagas; Maria Almeida
Journal:  Mol Endocrinol       Date:  2007-07-10

9.  Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

Authors:  G G Kuiper; J G Lemmen; B Carlsson; J C Corton; S H Safe; P T van der Saag; B van der Burg; J A Gustafsson
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736

10.  Comparative study of antioxidant properties and total phenolic content of 30 plant extracts of industrial interest using DPPH, ABTS, FRAP, SOD, and ORAC assays.

Authors:  Stéphanie Dudonné; Xavier Vitrac; Philippe Coutière; Marion Woillez; Jean-Michel Mérillon
Journal:  J Agric Food Chem       Date:  2009-03-11       Impact factor: 5.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.